1Paydas S,K:lic B,Sahin B,et al.Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey.BrJ Cancer,1999,80:1303-1305.
2Pivetti S,Novarino A,Merico F,et al.High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders.Br J Haematol,1996,95:204-209.
3Vallisa, D., P. Bemuzzi, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience [J]. J Clin Oncol,2005, 23(3): 468-73.
4Saadoun, D., F. Suarez, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? [J]. Blood,2005, 105(1): 74-6.
5Arcaini, L., S. Burcheri, et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT [J]. Ann Oncol, 2007, 18(2): 346-50.
6De Renzo, A., F. Perna, et al. (2008). "Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma[J]. Eur J Haematol,2008,81(1): 51-7.
7Salem, A. K. Prevalence of HCV among Yemeni patients with non-Hodgkin's lymphoma at AI-Thawra teaching hospital [J]. Gulf J Oncolog, 2009, (5): 22-9.
8Wolf AM, WolfD, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [J]. Clin Cancer Res, 2003,9:606 - 612.
9Ormandy LA, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J]. Cancer Res ,2005,65:2457 - 2464.
10Beyer M, Kochanek M, Darabi K, et al. Reduced frequencies and suppressive function of CD4 ^+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine[J]. Blood ,2005,106:2018 - 2025.
